Mail

UK markets closed

FTSE 100
8,146.86
-16.81(-0.21%)
FTSE 250
20,120.36
-75.59(-0.37%)
AIM
776.04
-4.39(-0.56%)
GBP/EUR
1.1845
-0.0034(-0.29%)
GBP/USD
1.2686
-0.0074(-0.58%)
Bitcoin GBP
52,292.42
+126.21(+0.24%)

How I founded Britain's most respected removals firm

'Doing removals defines you for the rest of your working life'

Eliem Therapeutics, Inc. (ELYM)

NasdaqGM - NasdaqGM Real-time price. Currency in USD

Add to watchlist

8.81

+0.12

(+1.38%)

At close: 04:00PM EDT

8.91

+0.10

(+1.14%)

After hours:

04:02PM EDT

Currency in USD

Valuation measures⁴

Market cap (intra-day)	262.12M
Enterprise value	157.31M
Trailing P/E	N/A
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	N/A
Price/book (mrq)	2.46
Enterprise value/revenue	N/A
Enterprise value/EBITDA	0.58

Trading information

Stock price history

Beta (5Y monthly)	-0.31
52-week change ³	219.20%
S&P500 52-week change ³	23.76%
52-week high ³	11.55
52-week low ³	2.34
50-day moving average ³	6.80
200-day moving average ³	3.71

Share statistics

Avg vol (3-month) ³	896.34k
Avg vol (10-day) ³	92.81k
Shares outstanding ⁵	29.75M
Implied shares outstanding ⁶	29.75M
Float ⁸	4.67M
% held by insiders ¹	25.18%
% held by institutions ¹	70.57%
Shares short (15 May 2024) ⁴	128.78k
Short ratio (15 May 2024) ⁴	0.22
Short % of float (15 May 2024) ⁴	1.25%
Short % of shares outstanding (15 May 2024) ⁴	0.44%
Shares short (prior month 15 Apr 2024) ⁴	601.08k

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	N/A
Last split factor ²	N/A
Last split date ³	N/A

Financial highlights

Fiscal year

Fiscal year ends	31 Dec 2023
Most-recent quarter (mrq)	31 Mar 2024

Profitability

Profit margin	0.00%
Operating margin (ttm)	0.00%

Management effectiveness

Return on assets (ttm)	-9.09%
Return on equity (ttm)	-13.01%

Income statement

Revenue (ttm)	N/A
Revenue per share (ttm)	N/A
Quarterly revenue growth (yoy)	N/A
Gross profit (ttm)	N/A
EBITDA	N/A
Net income avi to common (ttm)	-14.53M
Diluted EPS (ttm)	-0.52
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	105.03M
Total cash per share (mrq)	3.61
Total debt (mrq)	225k
Total debt/equity (mrq)	0.21%
Current ratio (mrq)	37.03
Book value per share (mrq)	3.84

Cash flow statement

Operating cash flow (ttm)	-7.24M
Levered free cash flow (ttm)	-2.53M